Back
Allied Properties Real Estate Investment Trust Vs. Madrigal Pharmaceuticals, Inc. Industry Stock Comparison
Sell
25
APYRF
Allied Properties Real Estate Investment Trust
Last Price:
$9.56
Seasonality Move:
1.27%
Buy
61
MDGL
Madrigal Pharmaceuticals, Inc.
Last Price:
$554.31
Seasonality Move:
13.5%
Sell
25
Allied Properties Real Estate Investment Trust (APYRF)
is a Sell
Is Allied Properties Real Estate Investment Trust a Buy, Sell or Hold?
-
The current Allied Properties Real Estate Investment Trust [APYRF] share price is $9.55. The Score for APYRF is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
APYRF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Madrigal Pharmaceuticals, Inc. (MDGL)
is a Buy
Is Madrigal Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Madrigal Pharmaceuticals, Inc. [MDGL] share price is $560.55. The Score for MDGL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APYRF Stock Price Chart
What is Allied Properties Real Estate Investment Trust's stock price today?
-
The Allied Properties Real Estate Investment Trust share price today is $9.55Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APYRF is experiencing selling pressure, which indicates risk of future bearish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals, Inc.'s stock price today?
-
The Madrigal Pharmaceuticals, Inc. share price today is $560.55The current trend is moderately bearish and MDGL is experiencing slight selling pressure.
APYRF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.39 | Sell |
| Relative Strength Index (14 RSI): | 40.74 | Sell |
| Chaikin Money Flow: | -55015 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.2 - 9.78) | Buy |
| Bollinger Bands (100): | (10.35 - 14.53) | Sell |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 17.99 | Buy |
| Relative Strength Index (14 RSI): | 55.16 | Buy |
| Chaikin Money Flow: | -62508 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (535.43 - 586.23) | Sell |
| Bollinger Bands (100): | (370.66 - 526.22) | Buy |
APYRF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.42 | Buy |
| 20-day SMA: | 9.38 | Buy |
| 50-day SMA: | 11.09 | Sell |
| 200-day SMA: | 12.08 | Sell |
| 8-day EMA: | 9.47 | Buy |
| 20-day EMA: | 9.65 | Sell |
| 50-day EMA: | 10.74 | Sell |
| 200-day EMA: | 12.09 | Sell |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 567.72 | Sell |
| 20-day SMA: | 570.52 | Sell |
| 50-day SMA: | 498.97 | Buy |
| 200-day SMA: | 378.32 | Buy |
| 8-day EMA: | 566.88 | Sell |
| 20-day EMA: | 557.22 | Buy |
| 50-day EMA: | 513.74 | Buy |
| 200-day EMA: | 405.46 | Buy |
Allied Properties Real Estate Investment Trust Earnings Growth & APYRF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals, Inc. Earnings Growth & MDGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.88 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.45 per share, and an increase next year of $15.15 per share.
Allied Properties Real Estate Investment Trust Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||